Method of In Vitro Diagnosis of a Neurological Disorder
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Apr 28, 2016
app pub date -
May 15, 2014
filing date -
May 15, 2013
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a new method for the in vitro diagnosis of a neurological disorder, more particularly of Alzheimer's disease (AD) and of mild cognitive impairment (MCI). The present invention also relates to the use of orexin-A (hypocretin-1), a specific fragment thereof, a nucleotide encoding the same or a combination thereof, as a biomarker for the in vitro diagnosis of a neurological disorder, more particularly of Alzheimer's disease (AD), alone or in combination with other known bio markers for the diagnosis of AD. The present invention finally relates to kits for the in vitro diagnosis of a neurological disorder, more particularly of AD, comprising means for the detection of orexin-A.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully